VARN2022: Shaping Global Vaccine Acceptance with Localized Knowledge
Sabin and the VARN organizing committee hosted the inaugural VARN Conference on March 1-3, 2022. The conference was a huge success, as 750+ participants registered to join us from across 75+ countries to hear global health professionals, behavioral researchers and policymakers share their research findings and discuss key strategies to support vaccine acceptance, demand and uptake.
We heard throughout the conference of the need for multidisciplinary action moving forward, and we are proud to share that VARN2022 registrants work in over 10 different sectors, with the majority of participants stemming from academia/research, national ministries/government agencies, and international non-governmental organizations/civil society organizations. Multi-sectoral engagement is vital to effect change as we translate these key research findings into policy and practice.
Keep an eye on this space for a full conference report – including next steps regarding technical working groups – to be released in the coming weeks.
Working with Sabin VAD leadership, the VARN2022 conference planning committee includes:
- Ève Dubé, PhD, VARN Chair, Quebec National Institute of Public Health, Canada
- Baldeep Dhaliwal, MSPH, Bloomberg School of Public Health, Johns Hopkins University, USA
- Momin Kazi, PhD candidate, MBBS, MPH Aga Khan University, Pakistan
- Freddy Eric Kitutu, PhD, Sustainable Pharmaceutical Systems Unit, School of Health Sciences, Makerere University, Uganda
- Rupali Limaye, PhD, MPH, MA, Bloomberg School of Public Health, Johns Hopkins University, USA
- Rubina Qasim, MSc, Institute of Nursing, Dow University of Health Sciences, Pakistan
- Holly Seale, PhD, MPH, School of Population Health, University of New South Wales, Australia
